RALEIGH, N.C., Nov. 18, 2013 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it will participate in two healthcare conferences in November and December, 2013.
Ken Reali, President and Chief Executive Officer, and Tim Shannon, Interim Chief Financial Officer, are scheduled to attend the Brean Capital 2013 Life Sciences Summit in New York, NY on Monday, November 25, 2013 and present at the 25th Annual Piper Jaffray Healthcare Conference in New York, NY on December 4, 2013.
Institutional investors that wish to request a meeting with Baxano Surgical should contact Brean Capital or Piper Jaffray.
About Baxano Surgical, Inc.
Baxano Surgical, Inc. is a medical device company focused on designing, developing, and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. Baxano Surgical currently markets the AxiaLIF® family of products for single and two level lower lumbar fusion, the VEO® lateral access and interbody fusion system, the iO-Flex® system, a proprietary set of flexible instruments used by surgeons during spinal decompression procedures and the iO-TomeTM instrument, which rapidly and precisely removes bone, specifically the facet joints, which is commonly performed in spinal fusion procedures. Baxano Surgical was founded in May 2000 and is headquartered in Raleigh, North Carolina. For more information, visit www.baxanosurgical.com.
AxiaLIF, VEO, and iO-Flex are registered trademarks of Baxano Surgical.
CONTACT: Investors: Westwicke Partners Mark Klausner, 443-213-0501 firstname.lastname@example.orgSource:Baxano Surgical, Inc.